Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis:

Caroline Stein, Hasan Nassereldine, Reed J D Sorensen, Joanne O Amlag, Catherine Bisignano, Sam Byrne, Emma Castro, Kaleb Coberly, James K Collins, Jeremy Dalos, Farah Daoud, Amanda Deen, Emmanuela Gakidou, John R Giles, Erin N Hulland, Bethany M Huntley, Kasey E Kinzel, Rafael Lozano, Ali H Mokdad, Tom Pham, David M Pigott, Robert C Reiner Jr., Theo Vos, Simon I Hay, Christopher J L Murray, Stephen S Lim

16 February, 2023

NZ Respiratory Research Review Issue 208

Thrombotic events following the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) in Aotearoa New Zealand: A self-controlled case series study:

Muireann Walton, Robert Tomkies, Thomas Teunissen Thomas Lumley, Timothy Hanlon

27 December, 2022

NZ Respiratory Research Review Issue 207

Associations between COVID-19 and hospitalisation with respiratory and non-respiratory conditions: a record linkage study:

Stacey L Rowe, Karin Leder, Kylie Dyson, Lalitha Sundaresan, Dennis Wollersheim, Brigid Lynch, Ifrah Abdullahi, Benjamin C Cowie, Nicola Stephens, Terence M Nolan, Sheena G Sullivan, Brett Sutton, Allen C Cheng

14 November, 2022

NZ Respiratory Research Review Issue 208

Home monitoring of lung function, symptoms and quality of life after admission with COVID-19 infection: The HOMECOMIN' study:

Gizal Nakshbandi, Catharina C. Moor, Esther J. Nossent, J. J. Miranda Geelhoed, Sara J. Baart, Bart G. Boerrigter, Joachim G. J. V. Aerts, Suzan F. M. Nijman, Helger Y. Santema, Merel E. Hellemons, Marlies S. Wijsenbeek

19 April, 2022

NZ Respiratory Research Review Issue 208

Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis:

Jonathan R Baker, PhD Mahdi Mahdi, BSc Dan V Nicolau Jr, PhD Sanjay Ramakrishnan, MBBS Prof Peter J Barnes, FRS Jodie L Simpson, PhD et al.

7 April, 2022

NZ Respiratory Research Review Issue 200

No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event:

Maxime Delrue, MD, PhD Alain Stépanian, PhD Sebastian Voicu, MD, PhD Kladoum Nassarmadji, MD Damien Sène, MD, PhD Philippe Bonnin, MD, PhD Jean-Philippe Kevorkian, MD, PhD Pierre-Olivier Sellier, MD, PhD Jean-Michel Molina, MD, PhD Marie Neuwirth, MD Dominique Vodovar, MD, PhD Stéphane Mouly, MD, PhD Alexandre Mebazaa, MD, PhD Bruno Mégarbane, MD, PhD Virginie Siguret, PhD

6 April, 2022

NZ Respiratory Research Review Issue 202

The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature:

Lesley J.J. Soril a,b , Ronald W. Damant a,c , Grace Y. Lam c , Maeve P. Smith c , Jason Weatherald d , Jean Bourbeau e , Paul Hernandez f , Michael K. Stickland

1 March, 2022

NZ Respiratory Research Review Issue 196

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study:

Ruvim Izikson, MD Daniel Brune, MD Jean-Sébastien Bolduc, PhD Pierre Bourron, PharmD Marion Fournier, MSc Tamala Mallett Moore, MD et al.

31 January, 2022

NZ Respiratory Research Review Issue 196

Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey :

Keir Elmslie James Philip, Sara Buttery, Parris Williams, Bavithra Vijayakumar, James Tonkin, Andrew Cumella, Lottie Renwick, Lizzie Ogden, Jennifer K Quint, Sebastian L Johnston, Michael I Polkey, Nicholas S Hopkinson

13 January, 2022

NZ Respiratory Research Review Issue 200

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial:

Seth Toback, MD Eva Galiza, MBBS Catherine Cosgrove, PhD James Galloway, PhD Anna L Goodman, DPhil Pauline A Swift, PhD et al.

17 November, 2021

NZ Respiratory Research Review Issue 196